Funding for “ghost” cell cancer therapy

Israel’s aMoon fund, has invested $5 million in the new NanoGhost anti-cancer therapy of Technion Professor Marcelle Machluf. (reported here previously). In lab tests NanoGhost reduced small lung carcinoma, prostate, and pancreatic cancer tumors, by as much as 85%.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *